Search Browse Earnings

Merus N.V. — SlamSEC

Merus N.V.

Pharmaceutical Preparations·3584 CM UTRECHT, DE

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$41.6M

FY 2024

Adj. EBITDA

-$158.8M

-381.8% margin

FY 2024

Net Income

-$131.2M

-315.5% margin

FY 2024

EPS (Diluted)

-$2.92

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$147.7M

FY 2024

Total Debt

—

Net Cash

$147.7M

FY 2024

Enterprise Value

—

Debt / EBITDA

0.9x

FY 2024

EV / EBITDA

—

Employees

—